Publication:
Predictors of atopic dermatitis phenotypes and severity: Roles of serum immunoglobulins and filaggrin gene mutation R501X

dc.contributor.authorÖZEN, AHMET OĞUZHAN
dc.contributor.authorBARIŞ, SAFA
dc.contributor.authorsErcan, H.; Ispir, T.; Kirac, D.; Baris, S.; Ozen, A.; Oztezcan, S.; Cengizlier, M. R.
dc.date.accessioned2022-03-12T18:08:56Z
dc.date.accessioned2026-01-10T16:58:04Z
dc.date.available2022-03-12T18:08:56Z
dc.date.issued2013
dc.description.abstractBackground: Atopic dermatitis (AD), the most common chronic relapsing skin condition of infancy and childhood, is a complex multifactorial disease, which arises from the interaction between strong genetic and environmental factors. Objective: To investigate the roles of several factors on the severity of AD including FLG R501X gene mutation, serum immunoglobulin (Ig) levels, atopy and accompanying allergic disorders. Method: Children were genotyped for the mutation in FLG R501X gene. Serum levels of major Ig isotypes, atopy and accompanying allergic disorders were assessed. Results: Study group consisted of 49 patients (M: 26, F: 23) with a mean age of 4.9 +/- 3.6 years and control group consisted of 50 children (M: 30, F: 20) with a mean age of 3.8 +/- 2.8 years. Genotyping of R501X mutation revealed risk alleles in none of the children in study group or control group. IgG z-scores were significantly higher in patients with AD compared to controls (-0.97 +/- 1.13 vs 1.48 +/- 1.02, p = 0.026). There was a positive trend in IgG z-scores and a negative trend in IgA z-scores across the severity of AD. History of recurrent infections was significantly associated with asthma and/or AR (47.8% in patients with asthma/AR vs 3.8% in those without). Children with low IgG or IgA levels presented at an earlier age with lower rates of atopy and mild type AD. Conclusion: In a sample of Turkish children, FLG R501X genotyping revealed no risk alleles in variable severities of AD or healthy controls. Our data suggest that IgG and IgA levels might have a role in phenotypic features of AD in terms of severity and atopic sensitisation. (c) 2011 SEICAP. Published by Elsevier Espana, S.L. All rights reserved.
dc.identifier.doi10.1016/j.aller.2012.03.004
dc.identifier.eissn1578-1267
dc.identifier.issn0301-0546
dc.identifier.pubmed22989708
dc.identifier.urihttps://hdl.handle.net/11424/231218
dc.identifier.wosWOS:000317542800003
dc.language.isoeng
dc.publisherELSEVIER DOYMA SL
dc.relation.ispartofALLERGOLOGIA ET IMMUNOPATHOLOGIA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAtopic dermatitis
dc.subjectFilaggrin R501X mutation
dc.subjectImmunoglobulin levels
dc.subjectChildren
dc.subjectOF-FUNCTION MUTATIONS
dc.subjectSUPPRESSOR T-CELLS
dc.subjectTRANSIENT HYPOGAMMAGLOBULINEMIA
dc.subjectCONFER SUSCEPTIBILITY
dc.subjectICHTHYOSIS VULGARIS
dc.subjectPERIPHERAL-BLOOD
dc.subjectECZEMA
dc.subjectASTHMA
dc.subjectCHILDREN
dc.subjectBARRIER
dc.titlePredictors of atopic dermatitis phenotypes and severity: Roles of serum immunoglobulins and filaggrin gene mutation R501X
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage93
oaire.citation.issue2
oaire.citation.startPage86
oaire.citation.titleALLERGOLOGIA ET IMMUNOPATHOLOGIA
oaire.citation.volume41

Files